Cargando…

Corneal opacity and copper levels of the Lewis syndrome after systemic chemotherapy

PURPOSE: To report a female patient of biclonal Lewis syndrome which consists of a trias: biclonal gammopathy of undetermined significance, paraproteinemic keratopathy in form of a brownish discoid opacification at the level of Descemet's membrane and hypercupremia. After several years there wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lisch, Walter, Vossmerbaeumer, Urs
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522692/
https://www.ncbi.nlm.nih.gov/pubmed/33015407
http://dx.doi.org/10.1016/j.ajoc.2020.100926
_version_ 1783588239445065728
author Lisch, Walter
Vossmerbaeumer, Urs
author_facet Lisch, Walter
Vossmerbaeumer, Urs
author_sort Lisch, Walter
collection PubMed
description PURPOSE: To report a female patient of biclonal Lewis syndrome which consists of a trias: biclonal gammopathy of undetermined significance, paraproteinemic keratopathy in form of a brownish discoid opacification at the level of Descemet's membrane and hypercupremia. After several years there was a conversion to multiple myeloma. Systemic chemotherapy led to a complete remission of multiple myeloma and to a normalization of the copper level in the blood that lasted five years. The corneal opacification remained unchanged. OBSERVATIONS: A currently 66-year-old woman suffered from biclonal Lewis syndrome. On both eyes there is a central discoid yellow-brownish discoloration in the Pre-Descemet’s layer. The corneal findings were unchanged after a follow up of eight years. However, there was a conversion to multiple myeloma (MM) type IgG with progressive anemia and suspicious bone lesions. A multiple systemic myeloma-therapy was indicated. Chemotherapy with subsequent tandem autologous-stem cell therapy (auto-SCT) was performed. The blood examination after this therapy showed a complete remission of multiple myeloma, and it was also very surprising that the serum copper level was within normal range. This finding remained unchanged over a period of five years. The bilateral corneal opacification was identical to that before chemotherapy. To the best of our knowledge, this represents the first observation of a normalization of copper levels in Lewis syndrome after chemotherapy. CONCLUSIONS AND IMPORTANCE: The Lewis syndrome represents a very rare disorder. The first case reported in Europe (Lisch et al., 2016)(1) showed a conversion from biclonal gammopathy of undetermined significance to MM after a follow-up of 17 years. Subjectively, the patient was in excellent health. The typical corneal, discoid brownish opacification at the level of Descemet's membrane is a suspicious hint of a copper disturbance for the ophthalmologist. The copper level of our patient was extremely elevated. The corneal opacification however, remained unchanged throughout the repeated ophthalmological examinations. In 2015, the conversion of our case with Lewis syndrome to MM performing chemotherapy in different steps and a twice auto-SCT resulted in a complete remission of MM and a normal range of the serum copper. The bilateral corneal opacification remained unchanged during an observation period of five years after chemotherapy.
format Online
Article
Text
id pubmed-7522692
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-75226922020-10-02 Corneal opacity and copper levels of the Lewis syndrome after systemic chemotherapy Lisch, Walter Vossmerbaeumer, Urs Am J Ophthalmol Case Rep Case Report PURPOSE: To report a female patient of biclonal Lewis syndrome which consists of a trias: biclonal gammopathy of undetermined significance, paraproteinemic keratopathy in form of a brownish discoid opacification at the level of Descemet's membrane and hypercupremia. After several years there was a conversion to multiple myeloma. Systemic chemotherapy led to a complete remission of multiple myeloma and to a normalization of the copper level in the blood that lasted five years. The corneal opacification remained unchanged. OBSERVATIONS: A currently 66-year-old woman suffered from biclonal Lewis syndrome. On both eyes there is a central discoid yellow-brownish discoloration in the Pre-Descemet’s layer. The corneal findings were unchanged after a follow up of eight years. However, there was a conversion to multiple myeloma (MM) type IgG with progressive anemia and suspicious bone lesions. A multiple systemic myeloma-therapy was indicated. Chemotherapy with subsequent tandem autologous-stem cell therapy (auto-SCT) was performed. The blood examination after this therapy showed a complete remission of multiple myeloma, and it was also very surprising that the serum copper level was within normal range. This finding remained unchanged over a period of five years. The bilateral corneal opacification was identical to that before chemotherapy. To the best of our knowledge, this represents the first observation of a normalization of copper levels in Lewis syndrome after chemotherapy. CONCLUSIONS AND IMPORTANCE: The Lewis syndrome represents a very rare disorder. The first case reported in Europe (Lisch et al., 2016)(1) showed a conversion from biclonal gammopathy of undetermined significance to MM after a follow-up of 17 years. Subjectively, the patient was in excellent health. The typical corneal, discoid brownish opacification at the level of Descemet's membrane is a suspicious hint of a copper disturbance for the ophthalmologist. The copper level of our patient was extremely elevated. The corneal opacification however, remained unchanged throughout the repeated ophthalmological examinations. In 2015, the conversion of our case with Lewis syndrome to MM performing chemotherapy in different steps and a twice auto-SCT resulted in a complete remission of MM and a normal range of the serum copper. The bilateral corneal opacification remained unchanged during an observation period of five years after chemotherapy. Elsevier 2020-09-18 /pmc/articles/PMC7522692/ /pubmed/33015407 http://dx.doi.org/10.1016/j.ajoc.2020.100926 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Lisch, Walter
Vossmerbaeumer, Urs
Corneal opacity and copper levels of the Lewis syndrome after systemic chemotherapy
title Corneal opacity and copper levels of the Lewis syndrome after systemic chemotherapy
title_full Corneal opacity and copper levels of the Lewis syndrome after systemic chemotherapy
title_fullStr Corneal opacity and copper levels of the Lewis syndrome after systemic chemotherapy
title_full_unstemmed Corneal opacity and copper levels of the Lewis syndrome after systemic chemotherapy
title_short Corneal opacity and copper levels of the Lewis syndrome after systemic chemotherapy
title_sort corneal opacity and copper levels of the lewis syndrome after systemic chemotherapy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522692/
https://www.ncbi.nlm.nih.gov/pubmed/33015407
http://dx.doi.org/10.1016/j.ajoc.2020.100926
work_keys_str_mv AT lischwalter cornealopacityandcopperlevelsofthelewissyndromeaftersystemicchemotherapy
AT vossmerbaeumerurs cornealopacityandcopperlevelsofthelewissyndromeaftersystemicchemotherapy